Sort   by:  
 Page size 
UnknownBrain-Derived Neurotrophic Factor Val66Met Gene Polymorphism Impacts on Migraine Susceptibility: A Meta-analysis of Case-Control Studies.
Not available
S-EPMC5410590 | biostudies-literature
UnknownEffect of Non-invasive Vagus Nerve Stimulation on Resting-State Electroencephalography and Laser-Evoked Potentials in Migraine Patients: Mechanistic Insights.
Not available
S-EPMC6146235 | biostudies-literature
UnknownChanges in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN).
Not available
S-EPMC7847867 | biostudies-literature
UnknownOnset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies.
Not available
S-EPMC6899640 | biostudies-literature
UnknownThe Smart Aging Platform for Assessing Early Phases of Cognitive Impairment in Patients With Neurodegenerative Diseases.
Not available
S-EPMC8005545 | biostudies-literature
UnknownMale sex accelerates cognitive decline in GBA1 Parkinson's disease.
Not available
S-EPMC11880540 | biostudies-literature
UnknownThe Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.
Not available
S-EPMC6379270 | biostudies-literature
UnknownProfiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells.
Not available
S-EPMC8247888 | biostudies-literature
UnknownCurrent Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.
Not available
S-EPMC5935650 | biostudies-literature
UnknownPsychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study.
Not available
S-EPMC8487575 | biostudies-literature
Sort   by:  
 Page size